BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2332Biotechnology
$29.28 −$0.66 (-2.20%)
Pre-market · Oct 6, 4:10 am ET · After hours $29.33 +0.17%
Open$30.14
Prev close$29.94
Day range$28.71 – $30.18
Volume6.28M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts16
Average target$90.47+209.0% vs. price
  • Buy 94%
  • Hold 6%
Low $38.00Now $29.28Avg $90.47High $125.00

Recent rating changes

The last 20 actions on file set price targets from $38.00 to $125.00, averaging $89.16.

DateFirmRatingTarget
23 Sep 2026 CCORF BUY $114.00
23 Sep 2026 Maxim Group BUY $70.00
23 Sep 2026 Truist Financial BUY $87.00
23 Sep 2026 Jefferies BUY $101.00
23 Sep 2026 B. Riley Securities BUY $85.00
23 Sep 2026 Lake Street BUY $89.00
22 Sep 2026 William Blair BUY –
22 Sep 2026 Maxim Group BUY $70.00
22 Sep 2026 BTIG BUY $125.00
22 Sep 2026 Truist Financial BUY $83.00
22 Sep 2026 Morgan Stanley BUY $95.00
22 Sep 2026 Stifel BUY $95.00
22 Sep 2026 Goldman Sachs HOLD $38.00
22 Sep 2026 H.C. Wainwright BUY $102.00
22 Sep 2026 Oppenheimer BUY $120.00
9 Sep 2026 B. Riley Securities BUY $85.00
14 Aug 2026 Cantor Fitzgerald BUY $100.00
11 Aug 2026 J.P. Morgan BUY $65.00
3 Aug 2026 Oppenheimer BUY $100.00
31 Jul 2026 Maxim Group BUY $70.00

Discussion

No comments yet — be the first to weigh in on VKTX.

Leave a comment

Scroll to Top